Click for best price
Adoptive Cell Transfer Therapy Market Size, Share 2023
This report aims to provide a comprehensive presentation of the global market for Adoptive Cell Transfer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adoptive Cell Transfer Therapy. This report contains market size and forecasts of Adoptive Cell Transfer Therapy in global, including the following market information:
Global Adoptive Cell Transfer Therapy Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Adoptive Cell Transfer Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
NK Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Adoptive Cell Transfer Therapy include Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech and Atara Biotherapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Adoptive Cell Transfer Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adoptive Cell Transfer Therapy Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Adoptive Cell Transfer Therapy Market Segment Percentages, by Type, 2022 (%)
NK
LAK
DC
CIK
CTL
TIL
TCR-T
CAR-T
Global Adoptive Cell Transfer Therapy Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Adoptive Cell Transfer Therapy Market Segment Percentages, by Application, 2022 (%)
Acute Lymphocytic Leukemia
NHL
Melanoma
Bladder Cancer
Lung Cancer
Head and Neck Cancer
Multiple Myeloma
Other
Global Adoptive Cell Transfer Therapy Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Adoptive Cell Transfer Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adoptive Cell Transfer Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Adoptive Cell Transfer Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis AG
Kite Pharma
Pfizer
Juno Therapeutics
Celgene Corporation
CARsgen Therapeutics
Sorrento Therapeutics
Legend Biotech
Atara Biotherapeutics
Aurora Biopharma
Autolus Therapeutics PLC
Bluebird
Carina Biotech
Athenex
Xiangxue Pharmaceutical (Xiangxue Precision)
Hengrui Yuanzheng
Eureka Therapeutics
WuXi Juno
Shenzhen Inno Immunity
Shenzhen Binde Bio
Kerui Bio
Adaptimmune
Altor Bioscience Corporation
Cellectis
Takara Bio
Unum Therapeutics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Adoptive Cell Transfer Therapy, market overview.
Chapter 2: Global Adoptive Cell Transfer Therapy market size in revenue.
Chapter 3: Detailed analysis of Adoptive Cell Transfer Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adoptive Cell Transfer Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Adoptive Cell Transfer Therapy Market, Global Outlook and Forecast 2023-2032 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
116 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Adoptive Cell Transfer Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adoptive Cell Transfer Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adoptive Cell Transfer Therapy Overall Market Size
2.1 Global Adoptive Cell Transfer Therapy Market Size: 2022 VS 2032
2.2 Global Adoptive Cell Transfer Therapy Market Size, Prospects & Forecasts: 2018-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Adoptive Cell Transfer Therapy Players in Global Market
3.2 Top Global Adoptive Cell Transfer Therapy Companies Ranked by Revenue
3.3 Global Adoptive Cell Transfer Therapy Revenue by Companies
3.4 Top 3 and Top 5 Adoptive Cell Transfer Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Adoptive Cell Transfer Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Adoptive Cell Transfer Therapy Players in Global Market
3.6.1 List of Global Tier 1 Adoptive Cell Transfer Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Adoptive Cell Transfer Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Adoptive Cell Transfer Therapy Market Size Markets, 2022 & 2032
4.1.2 NK
4.1.3 LAK
4.1.4 DC
4.1.5 CIK
4.1.6 CTL
4.1.7 TIL
4.1.8 TCR-T
4.1.9 CAR-T
4.2 By Type - Global Adoptive Cell Transfer Therapy Revenue & Forecasts
4.2.1 By Type - Global Adoptive Cell Transfer Therapy Revenue, 2018-2023
4.2.2 By Type - Global Adoptive Cell Transfer Therapy Revenue, 2024-2032
4.2.3 By Type - Global Adoptive Cell Transfer Therapy Revenue Market Share, 2018-2032
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Adoptive Cell Transfer Therapy Market Size, 2022 & 2032
5.1.2 Acute Lymphocytic Leukemia
5.1.3 NHL
5.1.4 Melanoma
5.1.5 Bladder Cancer
5.1.6 Lung Cancer
5.1.7 Head and Neck Cancer
5.1.8 Multiple Myeloma
5.1.9 Other
5.2 By Application - Global Adoptive Cell Transfer Therapy Revenue & Forecasts
5.2.1 By Application - Global Adoptive Cell Transfer Therapy Revenue, 2018-2023
5.2.2 By Application - Global Adoptive Cell Transfer Therapy Revenue, 2024-2032
5.2.3 By Application - Global Adoptive Cell Transfer Therapy Revenue Market Share, 2018-2032
6 Sights by Region
6.1 By Region - Global Adoptive Cell Transfer Therapy Market Size, 2022 & 2032
6.2 By Region - Global Adoptive Cell Transfer Therapy Revenue & Forecasts
6.2.1 By Region - Global Adoptive Cell Transfer Therapy Revenue, 2018-2023
6.2.2 By Region - Global Adoptive Cell Transfer Therapy Revenue, 2024-2032
6.2.3 By Region - Global Adoptive Cell Transfer Therapy Revenue Market Share, 2018-2032
6.3 North America
6.3.1 By Country - North America Adoptive Cell Transfer Therapy Revenue, 2018-2032
6.3.2 US Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.3.3 Canada Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.3.4 Mexico Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.4 Europe
6.4.1 By Country - Europe Adoptive Cell Transfer Therapy Revenue, 2018-2032
6.4.2 Germany Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.4.3 France Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.4.4 U.K. Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.4.5 Italy Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.4.6 Russia Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.4.7 Nordic Countries Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.4.8 Benelux Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.5 Asia
6.5.1 By Region - Asia Adoptive Cell Transfer Therapy Revenue, 2018-2032
6.5.2 China Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.5.3 Japan Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.5.4 South Korea Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.5.5 Southeast Asia Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.5.6 India Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.6 South America
6.6.1 By Country - South America Adoptive Cell Transfer Therapy Revenue, 2018-2032
6.6.2 Brazil Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.6.3 Argentina Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Adoptive Cell Transfer Therapy Revenue, 2018-2032
6.7.2 Turkey Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.7.3 Israel Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.7.4 Saudi Arabia Adoptive Cell Transfer Therapy Market Size, 2018-2032
6.7.5 UAE Adoptive Cell Transfer Therapy Market Size, 2018-2032
7 Adoptive Cell Transfer Therapy Companies Profiles
7.1 Novartis AG
7.1.1 Novartis AG Company Summary
7.1.2 Novartis AG Business Overview
7.1.3 Novartis AG Adoptive Cell Transfer Therapy Major Product Offerings
7.1.4 Novartis AG Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.1.5 Novartis AG Key News & Latest Developments
7.2 Kite Pharma
7.2.1 Kite Pharma Company Summary
7.2.2 Kite Pharma Business Overview
7.2.3 Kite Pharma Adoptive Cell Transfer Therapy Major Product Offerings
7.2.4 Kite Pharma Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.2.5 Kite Pharma Key News & Latest Developments
7.3 Pfizer
7.3.1 Pfizer Company Summary
7.3.2 Pfizer Business Overview
7.3.3 Pfizer Adoptive Cell Transfer Therapy Major Product Offerings
7.3.4 Pfizer Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.3.5 Pfizer Key News & Latest Developments
7.4 Juno Therapeutics
7.4.1 Juno Therapeutics Company Summary
7.4.2 Juno Therapeutics Business Overview
7.4.3 Juno Therapeutics Adoptive Cell Transfer Therapy Major Product Offerings
7.4.4 Juno Therapeutics Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.4.5 Juno Therapeutics Key News & Latest Developments
7.5 Celgene Corporation
7.5.1 Celgene Corporation Company Summary
7.5.2 Celgene Corporation Business Overview
7.5.3 Celgene Corporation Adoptive Cell Transfer Therapy Major Product Offerings
7.5.4 Celgene Corporation Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.5.5 Celgene Corporation Key News & Latest Developments
7.6 CARsgen Therapeutics
7.6.1 CARsgen Therapeutics Company Summary
7.6.2 CARsgen Therapeutics Business Overview
7.6.3 CARsgen Therapeutics Adoptive Cell Transfer Therapy Major Product Offerings
7.6.4 CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.6.5 CARsgen Therapeutics Key News & Latest Developments
7.7 Sorrento Therapeutics
7.7.1 Sorrento Therapeutics Company Summary
7.7.2 Sorrento Therapeutics Business Overview
7.7.3 Sorrento Therapeutics Adoptive Cell Transfer Therapy Major Product Offerings
7.7.4 Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.7.5 Sorrento Therapeutics Key News & Latest Developments
7.8 Legend Biotech
7.8.1 Legend Biotech Company Summary
7.8.2 Legend Biotech Business Overview
7.8.3 Legend Biotech Adoptive Cell Transfer Therapy Major Product Offerings
7.8.4 Legend Biotech Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.8.5 Legend Biotech Key News & Latest Developments
7.9 Atara Biotherapeutics
7.9.1 Atara Biotherapeutics Company Summary
7.9.2 Atara Biotherapeutics Business Overview
7.9.3 Atara Biotherapeutics Adoptive Cell Transfer Therapy Major Product Offerings
7.9.4 Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.9.5 Atara Biotherapeutics Key News & Latest Developments
7.10 Aurora Biopharma
7.10.1 Aurora Biopharma Company Summary
7.10.2 Aurora Biopharma Business Overview
7.10.3 Aurora Biopharma Adoptive Cell Transfer Therapy Major Product Offerings
7.10.4 Aurora Biopharma Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.10.5 Aurora Biopharma Key News & Latest Developments
7.11 Autolus Therapeutics PLC
7.11.1 Autolus Therapeutics PLC Company Summary
7.11.2 Autolus Therapeutics PLC Business Overview
7.11.3 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Major Product Offerings
7.11.4 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.11.5 Autolus Therapeutics PLC Key News & Latest Developments
7.12 Bluebird
7.12.1 Bluebird Company Summary
7.12.2 Bluebird Business Overview
7.12.3 Bluebird Adoptive Cell Transfer Therapy Major Product Offerings
7.12.4 Bluebird Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.12.5 Bluebird Key News & Latest Developments
7.13 Carina Biotech
7.13.1 Carina Biotech Company Summary
7.13.2 Carina Biotech Business Overview
7.13.3 Carina Biotech Adoptive Cell Transfer Therapy Major Product Offerings
7.13.4 Carina Biotech Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.13.5 Carina Biotech Key News & Latest Developments
7.14 Athenex
7.14.1 Athenex Company Summary
7.14.2 Athenex Business Overview
7.14.3 Athenex Adoptive Cell Transfer Therapy Major Product Offerings
7.14.4 Athenex Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.14.5 Athenex Key News & Latest Developments
7.15 Xiangxue Pharmaceutical (Xiangxue Precision)
7.15.1 Xiangxue Pharmaceutical (Xiangxue Precision) Company Summary
7.15.2 Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
7.15.3 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Major Product Offerings
7.15.4 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.15.5 Xiangxue Pharmaceutical (Xiangxue Precision) Key News & Latest Developments
7.16 Hengrui Yuanzheng
7.16.1 Hengrui Yuanzheng Company Summary
7.16.2 Hengrui Yuanzheng Business Overview
7.16.3 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Major Product Offerings
7.16.4 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.16.5 Hengrui Yuanzheng Key News & Latest Developments
7.17 Eureka Therapeutics
7.17.1 Eureka Therapeutics Company Summary
7.17.2 Eureka Therapeutics Business Overview
7.17.3 Eureka Therapeutics Adoptive Cell Transfer Therapy Major Product Offerings
7.17.4 Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.17.5 Eureka Therapeutics Key News & Latest Developments
7.18 WuXi Juno
7.18.1 WuXi Juno Company Summary
7.18.2 WuXi Juno Business Overview
7.18.3 WuXi Juno Adoptive Cell Transfer Therapy Major Product Offerings
7.18.4 WuXi Juno Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.18.5 WuXi Juno Key News & Latest Developments
7.19 Shenzhen Inno Immunity
7.19.1 Shenzhen Inno Immunity Company Summary
7.19.2 Shenzhen Inno Immunity Business Overview
7.19.3 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Major Product Offerings
7.19.4 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.19.5 Shenzhen Inno Immunity Key News & Latest Developments
7.20 Shenzhen Binde Bio
7.20.1 Shenzhen Binde Bio Company Summary
7.20.2 Shenzhen Binde Bio Business Overview
7.20.3 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Major Product Offerings
7.20.4 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.20.5 Shenzhen Binde Bio Key News & Latest Developments
7.21 Kerui Bio
7.21.1 Kerui Bio Company Summary
7.21.2 Kerui Bio Business Overview
7.21.3 Kerui Bio Adoptive Cell Transfer Therapy Major Product Offerings
7.21.4 Kerui Bio Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.21.5 Kerui Bio Key News & Latest Developments
7.22 Adaptimmune
7.22.1 Adaptimmune Company Summary
7.22.2 Adaptimmune Business Overview
7.22.3 Adaptimmune Adoptive Cell Transfer Therapy Major Product Offerings
7.22.4 Adaptimmune Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.22.5 Adaptimmune Key News & Latest Developments
7.23 Altor Bioscience Corporation
7.23.1 Altor Bioscience Corporation Company Summary
7.23.2 Altor Bioscience Corporation Business Overview
7.23.3 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Major Product Offerings
7.23.4 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.23.5 Altor Bioscience Corporation Key News & Latest Developments
7.24 Cellectis
7.24.1 Cellectis Company Summary
7.24.2 Cellectis Business Overview
7.24.3 Cellectis Adoptive Cell Transfer Therapy Major Product Offerings
7.24.4 Cellectis Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.24.5 Cellectis Key News & Latest Developments
7.25 Takara Bio
7.25.1 Takara Bio Company Summary
7.25.2 Takara Bio Business Overview
7.25.3 Takara Bio Adoptive Cell Transfer Therapy Major Product Offerings
7.25.4 Takara Bio Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.25.5 Takara Bio Key News & Latest Developments
7.26 Unum Therapeutics
7.26.1 Unum Therapeutics Company Summary
7.26.2 Unum Therapeutics Business Overview
7.26.3 Unum Therapeutics Adoptive Cell Transfer Therapy Major Product Offerings
7.26.4 Unum Therapeutics Adoptive Cell Transfer Therapy Revenue in Global Market (2018-2023)
7.26.5 Unum Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Adoptive Cell Transfer Therapy Market Opportunities & Trends in Global Market
Table 2. Adoptive Cell Transfer Therapy Market Drivers in Global Market
Table 3. Adoptive Cell Transfer Therapy Market Restraints in Global Market
Table 4. Key Players of Adoptive Cell Transfer Therapy in Global Market
Table 5. Top Adoptive Cell Transfer Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Adoptive Cell Transfer Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Adoptive Cell Transfer Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Adoptive Cell Transfer Therapy Product Type
Table 9. List of Global Tier 1 Adoptive Cell Transfer Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adoptive Cell Transfer Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2022 & 2032
Table 12. By Type - Adoptive Cell Transfer Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Adoptive Cell Transfer Therapy Revenue in Global (US$, Mn), 2024-2032
Table 14. By Application ? Global Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2022 & 2032
Table 15. By Application - Adoptive Cell Transfer Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Adoptive Cell Transfer Therapy Revenue in Global (US$, Mn), 2024-2032
Table 17. By Region ? Global Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2022 & 2032
Table 18. By Region - Global Adoptive Cell Transfer Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Adoptive Cell Transfer Therapy Revenue (US$, Mn), 2024-2032
Table 20. By Country - North America Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2024-2032
Table 22. By Country - Europe Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2024-2032
Table 24. By Region - Asia Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2024-2032
Table 26. By Country - South America Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2024-2032
Table 28. By Country - Middle East & Africa Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2024-2032
Table 30. Novartis AG Company Summary
Table 31. Novartis AG Adoptive Cell Transfer Therapy Product Offerings
Table 32. Novartis AG Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Novartis AG Key News & Latest Developments
Table 34. Kite Pharma Company Summary
Table 35. Kite Pharma Adoptive Cell Transfer Therapy Product Offerings
Table 36. Kite Pharma Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Kite Pharma Key News & Latest Developments
Table 38. Pfizer Company Summary
Table 39. Pfizer Adoptive Cell Transfer Therapy Product Offerings
Table 40. Pfizer Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Pfizer Key News & Latest Developments
Table 42. Juno Therapeutics Company Summary
Table 43. Juno Therapeutics Adoptive Cell Transfer Therapy Product Offerings
Table 44. Juno Therapeutics Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Juno Therapeutics Key News & Latest Developments
Table 46. Celgene Corporation Company Summary
Table 47. Celgene Corporation Adoptive Cell Transfer Therapy Product Offerings
Table 48. Celgene Corporation Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Celgene Corporation Key News & Latest Developments
Table 50. CARsgen Therapeutics Company Summary
Table 51. CARsgen Therapeutics Adoptive Cell Transfer Therapy Product Offerings
Table 52. CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. CARsgen Therapeutics Key News & Latest Developments
Table 54. Sorrento Therapeutics Company Summary
Table 55. Sorrento Therapeutics Adoptive Cell Transfer Therapy Product Offerings
Table 56. Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Sorrento Therapeutics Key News & Latest Developments
Table 58. Legend Biotech Company Summary
Table 59. Legend Biotech Adoptive Cell Transfer Therapy Product Offerings
Table 60. Legend Biotech Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Legend Biotech Key News & Latest Developments
Table 62. Atara Biotherapeutics Company Summary
Table 63. Atara Biotherapeutics Adoptive Cell Transfer Therapy Product Offerings
Table 64. Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Atara Biotherapeutics Key News & Latest Developments
Table 66. Aurora Biopharma Company Summary
Table 67. Aurora Biopharma Adoptive Cell Transfer Therapy Product Offerings
Table 68. Aurora Biopharma Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Aurora Biopharma Key News & Latest Developments
Table 70. Autolus Therapeutics PLC Company Summary
Table 71. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Product Offerings
Table 72. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. Autolus Therapeutics PLC Key News & Latest Developments
Table 74. Bluebird Company Summary
Table 75. Bluebird Adoptive Cell Transfer Therapy Product Offerings
Table 76. Bluebird Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Bluebird Key News & Latest Developments
Table 78. Carina Biotech Company Summary
Table 79. Carina Biotech Adoptive Cell Transfer Therapy Product Offerings
Table 80. Carina Biotech Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. Carina Biotech Key News & Latest Developments
Table 82. Athenex Company Summary
Table 83. Athenex Adoptive Cell Transfer Therapy Product Offerings
Table 84. Athenex Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Athenex Key News & Latest Developments
Table 86. Xiangxue Pharmaceutical (Xiangxue Precision) Company Summary
Table 87. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Product Offerings
Table 88. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. Xiangxue Pharmaceutical (Xiangxue Precision) Key News & Latest Developments
Table 90. Hengrui Yuanzheng Company Summary
Table 91. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Product Offerings
Table 92. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 93. Hengrui Yuanzheng Key News & Latest Developments
Table 94. Eureka Therapeutics Company Summary
Table 95. Eureka Therapeutics Adoptive Cell Transfer Therapy Product Offerings
Table 96. Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 97. Eureka Therapeutics Key News & Latest Developments
Table 98. WuXi Juno Company Summary
Table 99. WuXi Juno Adoptive Cell Transfer Therapy Product Offerings
Table 100. WuXi Juno Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 101. WuXi Juno Key News & Latest Developments
Table 102. Shenzhen Inno Immunity Company Summary
Table 103. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Product Offerings
Table 104. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 105. Shenzhen Inno Immunity Key News & Latest Developments
Table 106. Shenzhen Binde Bio Company Summary
Table 107. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Product Offerings
Table 108. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 109. Shenzhen Binde Bio Key News & Latest Developments
Table 110. Kerui Bio Company Summary
Table 111. Kerui Bio Adoptive Cell Transfer Therapy Product Offerings
Table 112. Kerui Bio Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 113. Kerui Bio Key News & Latest Developments
Table 114. Adaptimmune Company Summary
Table 115. Adaptimmune Adoptive Cell Transfer Therapy Product Offerings
Table 116. Adaptimmune Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 117. Adaptimmune Key News & Latest Developments
Table 118. Altor Bioscience Corporation Company Summary
Table 119. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Product Offerings
Table 120. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 121. Altor Bioscience Corporation Key News & Latest Developments
Table 122. Cellectis Company Summary
Table 123. Cellectis Adoptive Cell Transfer Therapy Product Offerings
Table 124. Cellectis Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 125. Cellectis Key News & Latest Developments
Table 126. Takara Bio Company Summary
Table 127. Takara Bio Adoptive Cell Transfer Therapy Product Offerings
Table 128. Takara Bio Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 129. Takara Bio Key News & Latest Developments
Table 130. Unum Therapeutics Company Summary
Table 131. Unum Therapeutics Adoptive Cell Transfer Therapy Product Offerings
Table 132. Unum Therapeutics Adoptive Cell Transfer Therapy Revenue (US$, Mn) & (2018-2023)
Table 133. Unum Therapeutics Key News & Latest Developments
List of Figures
Figure 1. Adoptive Cell Transfer Therapy Segment by Type in 2022
Figure 2. Adoptive Cell Transfer Therapy Segment by Application in 2022
Figure 3. Global Adoptive Cell Transfer Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Adoptive Cell Transfer Therapy Market Size: 2022 VS 2032 (US$, Mn)
Figure 6. Global Adoptive Cell Transfer Therapy Revenue, 2018-2032 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Adoptive Cell Transfer Therapy Revenue in 2022
Figure 8. By Type - Global Adoptive Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 9. By Application - Global Adoptive Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 10. By Type - Global Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 11. By Type - Global Adoptive Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 12. By Application - Global Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2022 & 2032
Figure 13. By Application - Global Adoptive Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 14. By Region - Global Adoptive Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 15. By Country - North America Adoptive Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 16. US Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 17. Canada Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 18. Mexico Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 19. By Country - Europe Adoptive Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 20. Germany Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 21. France Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 22. U.K. Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 23. Italy Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 24. Russia Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 25. Nordic Countries Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 26. Benelux Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 27. By Region - Asia Adoptive Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 28. China Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 29. Japan Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 30. South Korea Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 31. Southeast Asia Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 32. India Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 33. By Country - South America Adoptive Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 34. Brazil Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 35. Argentina Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 36. By Country - Middle East & Africa Adoptive Cell Transfer Therapy Revenue Market Share, 2018-2032
Figure 37. Turkey Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 38. Israel Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 39. Saudi Arabia Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 40. UAE Adoptive Cell Transfer Therapy Revenue, (US$, Mn), 2018-2032
Figure 41. Novartis AG Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Kite Pharma Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Pfizer Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Juno Therapeutics Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Celgene Corporation Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. CARsgen Therapeutics Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Sorrento Therapeutics Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Legend Biotech Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Atara Biotherapeutics Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Aurora Biopharma Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Bluebird Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Carina Biotech Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Athenex Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Hengrui Yuanzheng Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 57. Eureka Therapeutics Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 58. WuXi Juno Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 59. Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 60. Shenzhen Binde Bio Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 61. Kerui Bio Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 62. Adaptimmune Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 63. Altor Bioscience Corporation Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 64. Cellectis Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 65. Takara Bio Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 66. Unum Therapeutics Adoptive Cell Transfer Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
